214 related articles for article (PubMed ID: 35477165)
21. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
[TBL] [Abstract][Full Text] [Related]
22. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
[TBL] [Abstract][Full Text] [Related]
23. Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas.
Dourado MR; Machado RA; Paranaíba LMR; González-Arriagada WA; da Silva SD; Sawazaki-Calone Í; Graner E; Salo T; Coletta RD
Oral Dis; 2022 May; 28(4):1085-1093. PubMed ID: 33615627
[TBL] [Abstract][Full Text] [Related]
24. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
25. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
26. [Effect of human trophoblast cell-surface antigen 2 gene expression by RNA interference on proliferation and apoptosis of tongue squamous cell carcinoma and its mechanism].
Fang Z; Chen S; Zhao JF; Sun Q; Qiu F; Li XM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Sep; 53(9):640-644. PubMed ID: 30196628
[No Abstract] [Full Text] [Related]
27. Targeting Trop2 in solid tumors: a look into structures and novel epitopes.
Liu X; Li J; Deng J; Zhao J; Zhao G; Zhang T; Jiang H; Liang B; Xing D; Wang J
Front Immunol; 2023; 14():1332489. PubMed ID: 38179054
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
[TBL] [Abstract][Full Text] [Related]
30. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors.
Burandt E; Lübbersmeyer F; Gorbokon N; Büscheck F; Luebke AM; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Simon R; Uhlig R; Wilczak W; Steurer S; Minner S; Krech R; Dum D; Krech T; Marx AH; Bernreuther C
Biomark Res; 2021 Jun; 9(1):44. PubMed ID: 34090526
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
Han C; Perrone E; Zeybek B; Bellone S; Tymon-Rosario J; Altwerger G; Menderes G; Feinberg J; Haines K; Muller Karger ME; Bianchi A; Zammataro L; Manzano A; Bonazzoli E; Manara P; Buza N; Hui P; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Lopez S; Santin AD
Gynecol Oncol; 2020 Feb; 156(2):430-438. PubMed ID: 31839338
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma.
Zhang Y; Wang H; Overman M; Katz MH; Wang H
Hum Pathol; 2023 Sep; 139():117-125. PubMed ID: 37516386
[TBL] [Abstract][Full Text] [Related]
34. The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon.
Ahmed Y; Berenguer-Pina JJ; Mahgoub T
Oncology; 2021; 99(10):673-680. PubMed ID: 34280931
[TBL] [Abstract][Full Text] [Related]
35. The Significance of TROP2 Expression in Predicting
Kong JS; Kim HJ; Kim MJ; Kim A; Lee D; Han K; Park S; Koh JS; Myung JK
J Pathol Transl Med; 2018 Jan; 52(1):14-20. PubMed ID: 29228520
[TBL] [Abstract][Full Text] [Related]
36. The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.
Shen M; Liu S; Stoyanova T
Am J Clin Exp Urol; 2021; 9(1):73-87. PubMed ID: 33816696
[TBL] [Abstract][Full Text] [Related]
37. Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer.
Coates JT; Sun S; Leshchiner I; Thimmiah N; Martin EE; McLoughlin D; Danysh BP; Slowik K; Jacobs RA; Rhrissorrakrai K; Utro F; Levovitz C; Denault E; Walmsley CS; Kambadakone A; Stone JR; Isakoff SJ; Parida L; Juric D; Getz G; Bardia A; Ellisen LW
Cancer Discov; 2021 Oct; 11(10):2436-2445. PubMed ID: 34404686
[TBL] [Abstract][Full Text] [Related]
38. Trophoblast Cell Surface Antigen 2 (Trop-2) Protein is Highly Expressed in Salivary Gland Carcinomas and Represents a Potential Therapeutic Target.
Wolber P; Nachtsheim L; Hoffmann F; Klußmann JP; Meyer M; von Eggeling F; Guntinas-Lichius O; Quaas A; Arolt C
Head Neck Pathol; 2021 Dec; 15(4):1147-1155. PubMed ID: 33886073
[TBL] [Abstract][Full Text] [Related]
39. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
Menz A; Gorbokon N; Viehweger F; Lennartz M; Hube-Magg C; Hornsteiner L; Kluth M; Völkel C; Luebke AM; Fraune C; Uhlig R; Minner S; Dum D; Höflmayer D; Sauter G; Simon R; Burandt E; Clauditz TS; Lebok P; Jacobsen F; Steurer S; Krech T; Marx AH; Bernreuther C
Int J Surg Pathol; 2023 Sep; 31(6):927-938. PubMed ID: 35946088
[TBL] [Abstract][Full Text] [Related]
40. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
